首页> 外文期刊>Journal of Child and Adolescent Psychopharmacology >Predictors of Remission, Schizophrenia, and Bipolar Disorder in Adolescents with Brief Psychotic Disorder or Psychotic Disorder Not Otherwise Specified Considered At Very High Risk for Schizophrenia
【24h】

Predictors of Remission, Schizophrenia, and Bipolar Disorder in Adolescents with Brief Psychotic Disorder or Psychotic Disorder Not Otherwise Specified Considered At Very High Risk for Schizophrenia

机译:患有短暂性精神病或精神病的青少年的缓解,精神分裂症和双相情感障碍的预测因子,除非另有说明,否则认为精神分裂症的风险很高

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: The aim of this study was to examine predictors of diagnostic and symptomatic outcome in adolescents with either psychotic disorder not otherwise specified (PsyNOS) or brief psychotic disorder (BrPsy) followed in a schizophrenia prodromal program.nnMethods: As part of a naturalistic study of adolescents considered at clinical high risk for schizophrenia, 26 youths (mean age, 15.9 ± 2.6 years, 65.4% male) with psychosis not fulfilling criteria for schizophrenia/schizoaffective disorder and diagnosed with PsyNOS or BrPsy were evaluated for predictors of diagnostic and symptomatic outcome after at least 6 (mean, 22.8 ± 19.4) months follow up.nnResults: Progression to schizophrenia, schizoaffective disorder, or psychotic bipolar disorder (n = 10, 38.5%) was predicted by fulfilling criteria for schizotypal personality disorder at baseline (p = 0.046). Development of schizophrenia/schizoaffective disorder (n = 7, 27.0%) was associated with worse executive functioning (p = 0.029) and absence of anxiety disorders (p = 0.027). Conversely, progression to bipolar disorder (n = 4, 15.4%), with (n = 3, 11.5%) or without (n = 1, 3.8%) psychosis, was associated with the presence of anxiety disorders (p = 0.014). Remission of all psychotic as well as attenuated positive or negative symptoms (n = 5, 19.4%) was predicted by Hispanic ethnicity (p = 0.0047), an initial diagnosis of BrPsy (p = 0.014), longer duration of antidepressant treatment (p = 0.035), and better attention at baseline (p = 0.042).nnConclusions: Results from this preliminary study suggest that patients with PsyNOS, BrPsy, or schizotypal personality disorder features in adolescence should be followed as separate risk groups in prodromal studies of schizophrenia and bipolar disorder. Executive function deficits and absence of anxiety disorders may be risk markers for schizophrenia, while presence of anxiety disorders may be linked to bipolar disorder risk. After achieving full remission, patients with sudden onset of psychosis and brief episodes could once be given the option of careful, supervised treatment discontinuation. The potential salutary effect of antidepressants during the psychotic prodrome and presence of characteristics differentiating patients at risk for schizophrenia or bipolar disorder should be investigated further.
机译:目的:本研究的目的是检查精神分裂症前驱程序后未明确说明的精神病(PsyNOS)或短暂性精神病(BrPsy)的青少年诊断和症状预后的预测因素。nn方法:作为自然研究的一部分对被认为具有精神分裂症临床高风险的青少年中,对26名青年(平均年龄,15.9±2.6岁,男性的65.4%)未达到精神分裂症/精神分裂性情感障碍标准且被诊断为PsyNOS或BrPsy的精神病进行了诊断和症状预后的评估至少随访6(平均22.8±19.4)个月。nn结果:通过在基线时达到精神分裂型人格障碍的标准,预测到了精神分裂症,精神分裂性情感障碍或精神病性双相情感障碍(n = 10,38.5%)。 0.046)。精神分裂症/精神分裂症(n = 7,27.0%)的发展与执行功能恶化(p = 0.029)和缺乏焦虑症(p = 0.027)有关。相反,发展为双相情感障碍(n = 4、15.4%),有(n = 3、11.5%)或没有(n = 1、3.8%)精神病与焦虑症的存在相关(p = 0.014)。西班牙裔(p = 0.0047),BrPsy的初步诊断(p = 0.014),抗抑郁治疗的持续时间更长(p = 0.004),预示了所有精神病患者以及阳性或阴性症状减轻(n = 5,19.4%)。 0.035),并在基线时给予更好的关注(p = 0.042)。nn结论:这项初步研究的结果表明,在精神分裂症和双相型的前驱研究中,应将青春期PsyNOS,BrPsy或精神分裂型人格障碍患者作为单独的风险组进行追踪紊乱。执行功能缺陷和焦虑症的缺失可能是精神分裂症的危险标志,而焦虑症的存在可能与躁郁症的风险有关。在完全缓解后,一旦出现精神病突然发作和短暂发作的患者,就可以选择谨慎,有监督地停药。抗精神病药在精神病性综合征期间的潜在有益作用,以及是否存在使精神分裂症或双相情感障碍风险高的患者区别对待的特征。

著录项

  • 来源
  • 作者单位

    Christoph U. Correll, M.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.The Albert Einstein College of Medicine, Bronx, New York.Christopher W. Smith, Ph.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.Andrea M. Auther, Ph.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.Danielle McLaughlin, M.A.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.Manoj Shah, M.D.The Feinstein Institute for Medical Research, Brookdale Hospital, Brooklyn, New York.Carmel Foley, M.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.The Albert Einstein College of Medicine, Bronx, New York.Ruth Olsen, B.S.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.Todd Lencz, Ph.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.The Albert Einstein College of Medicine, Bronx, New York.The Feinstein Institute for Medical Research, Manhasset, New YorkJohn M. Kane, M.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.The Albert Einstein College of Medicine, Bronx, New York.The Feinstein Institute for Medical Research, Manhasset, New YorkBarbara A. Cornblatt, Ph.D.The Zucker Hillside Hospital, North Shore– Long Island Jewish Health System, Glen Oaks, New York.The Albert Einstein College of Medicine, Bronx, New York.The Feinstein Institute for Medical Research, Manhasset, New York;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    brief psychotic disorder (BrPsy); psychotic disorder not otherwise specified (PsyNOS);

    机译:短暂性精神病(BrPsy);未另作说明的精神病(PsyNOS);

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号